NCT07154966 2025-09-04
GYM-TASTE
Ankara Etlik City Hospital
Completed
Clinical Trials
12 trialsNCT00516724 2025-04-11
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel
AstraZeneca
Phase 1 Completed
NCT02855944 2023-06-09
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
pharmaand GmbH
Phase 3 Completed
NCT01367002 2023-05-17
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
Yale University
Phase 2 Completed
NCT02878122 2021-08-17
FaCliBioCCo
Rennes University Hospital
Completed
NCT00226915 2020-02-17
Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma
Japanese Gynecologic Oncology Group
Phase 3 Completed
NCT03562533 2019-02-28
Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer
Konkuk University Medical Center
Completed
NCT00584857 2017-01-27
A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer
University of Alabama at Birmingham
Phase 2 Completed
NCT00538603 2015-12-17
Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)
King Faisal Specialist Hospital & Research Center
Phase NA Completed
NCT00052468 2014-06-25
AGO-OVAR9
AGO Study Group
Phase 3 Completed
NCT00147680 2012-02-02
Uterine Papillary Serous Cancer (UPSC) Trial
Queensland Centre for Gynaecological Cancer
Phase 2 Completed
NCT00340184 2010-10-19
A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients
Korean Gynecologic Oncology Group
Phase 2 Completed